Chromosome analysis in patients with bladder tumor

Area of Science:

• Oncology
• Cytogenetics
• Urology

Background:

• Bladder tumors exhibit varying degrees of differentiation and invasiveness.
• Cytogenetic alterations are implicated in cancer development and progression.
• Understanding chromosomal changes in bladder cancer is crucial for patient management.

Purpose of the Study:

• To investigate the correlation between cytogenetic abnormalities and tumor characteristics in bladder cancer patients.
• To assess the predictive value of chromosomal changes for tumor recurrence and prognosis.

Main Methods:

• Cytogenetic analysis was performed on tumor samples from 80 bladder cancer patients.
• Mitotic activity was assessed across different tumor grades (G1, G2, G3).
• Chromosome number (ploidy) and presence of marker chromosomes were analyzed.

Main Results:

• No significant difference in mitotic activity was observed among tumor grades G1, G2, and G3.
• Noninvasive tumors (G1) predominantly showed diploid or near-diploid chromosome numbers.
• Invasive tumors (G2 and G3) consistently exhibited polyploidy.
• Marker chromosomes were identified in 14 patients, with 9 experiencing early recurrence.
• A strong correlation was found between recurrence rate and numerical/structural chromosomal abnormalities.

Conclusions:

• Tumor invasiveness in bladder cancer is associated with polyploidy.
• Cytogenetic abnormalities, including numerical and structural changes, are significant predictors of recurrence.
• Chromosome analysis is a valuable tool for evaluating therapy effectiveness and patient prognosis in bladder tumors.